Schoen, Meriah S. http://orcid.org/0000-0003-4015-2247
Boland, Kelly M.
Christ, Shawn E.
Cui, Xiangqin
Ramakrishnan, Usha
Ziegler, Thomas R.
Alvarez, Jessica A.
Singh, Rani H.
Funding for this research was provided by:
University of Missouri Research Council
Article History
Received: 5 May 2023
Accepted: 21 July 2023
First Online: 29 July 2023
Declarations
:
: The present study was approved by the Internal Review Board at the University of Missouri (#2034504) and Emory University (#00002281), and was carried out in accordance with the provisions of the World Medical Association Declaration of Helsinki. Informed consent was obtained for all individuals prior to participation.
: Not applicable.
: SEC has served on advisory boards for BioMarin Pharmaceutical Inc, Synlogic Therapeutics, and Horizon Therapeutics. RHS has served on advisory boards for Danone and Synlogic Therapeutics. SEC and RHS have served as PI for research studies funded by BioMarin. MSS and KMB reported no biomedical financial interests or potential conflicts of interest. The authors confirm independence from the aforementioned entities; the content of the article has not been influenced by the entities.